Figure 2.
GW559090 acts primarily locally, not systemically, to improve DS-induced corneal barrier disruption. Geometric mean and upper 95% CL of intensity score of OGD uptake after 5 days of DS. N = 26–30. *P < 0.05; **P < 0.01 compared to control (DS5 versus NS; GW versus GW vehicle; mixed effects ANOVA of Log10 OGD data).